Axogen, Inc. Common Stock vs. ENDRA Life Sciences Inc. Common Stock
AXGN
Axogen, Inc. Common Stock
$43.78 +3.84%
VS NDRAENDRA Life Sciences Inc. Common Stock
$5.87 +4.45%
Axogen, Inc. Common Stock and ENDRA Life Sciences Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| AXGN | NDRA | |
|---|---|---|
| Market Cap | $2.27 billion | $8.43 million |
| Revenue (TTM) | $251.17 million | — |
| Net Income (TTM) | $-33,548,000 | $-5,916,657 |
AXGN leads on 2 of 3 size & scale factors.
Valuation
| AXGN | NDRA | |
|---|---|---|
| Price / Book | 8.84 | 1.34 |
| Price / Sales | 9.02 | — |
NDRA leads on 1 of 1 valuation factors.
Profitability
| AXGN | NDRA | |
|---|---|---|
| Net Margin | -13.36% | — |
| Return on Equity | -13.09% | -93.77% |
AXGN leads on 1 of 1 profitability factors.
Risk & Sentiment
| AXGN | NDRA | |
|---|---|---|
| Short Interest | 2.05% | 0.78% |
NDRA leads on 1 of 1 risk & sentiment factors.
Dig deeper: AXGN overview, AXGN financials, NDRA overview, NDRA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.